-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Scopus BioPharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2022.
- Scopus BioPharma Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$1.84M, a 71.8% increase year-over-year.
- Scopus BioPharma Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$11.7M, a 57.6% increase year-over-year.
- Scopus BioPharma Inc. annual Operating Income (Loss) for 2022 was -$11.7M, a 57.6% increase from 2021.
- Scopus BioPharma Inc. annual Operating Income (Loss) for 2021 was -$27.6M, a 172% decline from 2020.
- Scopus BioPharma Inc. annual Operating Income (Loss) for 2020 was -$10.2M, a 278% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)